These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8723456

  • 1. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM, Rybak MJ.
    Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries.
    Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA.
    J Chemother; 2000 Aug; 12(4):299-305. PubMed ID: 10949979
    [Abstract] [Full Text] [Related]

  • 3. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW.
    Scand J Infect Dis; 1997 Aug; 29(3):255-7. PubMed ID: 9255885
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
    Arguedas AG, Arrieta AC, Stutman HR, Akaniro JC, Marks MI.
    J Antimicrob Chemother; 1991 Mar; 27(3):311-8. PubMed ID: 1903788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J, Verbist L.
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [Abstract] [Full Text] [Related]

  • 11. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.
    Thorburn CE, Knott SJ, Edwards DI.
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1973-9. PubMed ID: 9687392
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD, Powell M, Fah YS, Seymour A, Yuan M.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Aug; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
    Doern GV, Brueggemann A, Holley HP, Rauch AM.
    Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468
    [Abstract] [Full Text] [Related]

  • 18. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.
    Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910
    [Abstract] [Full Text] [Related]

  • 19. Streptococcus pneumoniae resistant to penicillin: incidence and potential therapeutic options.
    Rodriguez WJ, Schwartz RH, Akram S, Khan WN.
    Laryngoscope; 1995 Mar; 105(3 Pt 1):300-4. PubMed ID: 7877420
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG, Yachison C, Nichol K, Adam H, Noreddin AM, Hoban DJ, Karlowsky JA.
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.